Alzheimer's disease (AD) is one of the most difficult neurological disorders, because there are no means of biomarkers to predict the disease progression, nor is there a cure. Recently, on Nature Medicine, Thijssen et al and Janelidze et al reported an advanced diagnostic biomarker, plasma pTau181, for Alzheimer's disease.

Fig. 1 The potential of plasma tau as Alzheimer's disease (AD) biomarker.

 

 

 

Article Access: https://onlinelibrary.wiley.com/doi/10.1002/mco2.1

 

 

                                                                           

Website for MedComm: https://onlinelibrary.wiley.com/journal/26882663

Looking forward to your contributions.